Skip to main content
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. — Investor Relations & Filings

Ticker · SRPT ISIN · US8036071004 LEI · 549300IKDPIED8J8IG21 US Manufacturing
Filings indexed 1,061 across all filing types
Latest filing 2024-03-28 Regulatory Filings
Country US United States of America
Listing US SRPT

About Sarepta Therapeutics, Inc.

https://www.sarepta.com/

Sarepta Therapeutics is a commercial-stage biopharmaceutical company that engineers precision genetic medicines for rare diseases. The company's research and development efforts are centered on RNA-targeted therapeutics and gene therapies, with a primary focus on treating rare neuromuscular and central nervous system disorders. Sarepta aims to accelerate the drug development process from discovery to patient application and is building significant gene therapy manufacturing capabilities to support its mission.

Recent filings

Filing Released Lang Actions
S-8 POS
Regulatory Filings Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to Form S-8 Registration Statements filed with the SEC. It relates to amendments to registration statements for employee stock plans (2014, 2018, and 2024 Employment Commencement Incentive Plans). The document includes detailed information about the plans, share registration, and legal opinions, typical of SEC registration statement amendments. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and amendments to previously filed registration statements. Therefore, it fits best under Regulatory Filings (RNS). The document length is substantial and contains substantive content, not just a brief announcement, but it is not a financial report or other specific category. Hence, the classification is RNS with high confidence.
2024-03-28 English
4
Director's Dealing
2024-03-12 English
4
Director's Dealing
2024-03-12 English
4
Director's Dealing
2024-03-12 English
4
Director's Dealing
2024-03-12 English
4
Director's Dealing
2024-03-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.